NMD4C Members Presenting at Cure SMA Canada’s Winter Conference
About this Event, hosted by Cure SMA Canada
Thursday December 10 – Sunday December 13, 2020
Welcome to the Cure SMA Canada national SMA conference!
Cure SMA Canada are excited to be able to provide engaging, diverse, and informative topics for Canada’s SMA community to learn, heal and grow. Together we create an amazing cohesive community, learning from each other and making every tomorrow better than today.
Cure SMA would like to thank their sponsors, presenters and attendees.
NMD4C Presenters:
The NMD4C is excited to see many of its members present at this conference!
- Mise à jour sur le Risdiplam. Dr. Maryam Oskoui
- Nusinersen treatment update for adults with SMA. Dr. Erin K. O’Ferrall
- Care for the Caregiver. Rhonda Teichrob
- Spinraza – mise à jour pédiatrique. Dr. Nicolas Chrestian
- Pediatric update on Spinraza. Dr. Hernan Gonorazky
- Risdiplam update. Dr. Maryam Oskoui
- Peripheral pathology in SMA: Implications for clinical care (What goes wrong in SMA and how to fix it – lessons learned from recent studies). Dr. Rashmi Kothary
- Biomarkers for SMA. Dr. Robin Parks
- À la recherche du role d’SMN dans les neurones et muscles : une stratégie pour l’identification de nouvelles cibles thérapeutiques pour l’Amyotrophie Spinale Infantile. Dr. Jocelyn Côté
- Teens/adult transition and the importance of multidisciplinary care. Dr. Aaron Izenberg
- The Changing Landscape of Respiratory Care for SMA. Dr. Reshma Amin
Click Here for the full Agenda
Register Now!
Read next...
NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards
We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada.
NMD4C Launch Canadian Neuromuscular Clinical Trial Network
We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.
Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network
This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted.
MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants
Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.
SMA Outcome Measures Training for Physiotherapists and Occupational Therapists
To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.
Congratulations to the 2024 NMD4C Early Career Awards Recipients
We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.